https://www.selleckchem.com/pr....oducts/Abitrexate.ht
To investigate the symptom network structure of major depressive disorder (MDD) with mixed features and implications for treatment. In this post-hoc analysis of a previously reported randomized trial, patients meeting DSM-IV-TR criteria for MDD presenting with two or three manic symptoms (DSM-5 mixed features specifier) were randomized to 6 weeks of double-blind treatment with lurasidone 20-60mg/d (N=109) or placebo (N=10. The network structure of symptoms at baseline and their treatment moderating effects were investigated. Networ
Like
Comment
Share
